Delivery Order SPE2DB25D7068-SPE2DB25FTYBM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,214.54 to AmerisourceBergen Drug Corp for Solu-Cortef 100 mg Act-O-Vials, a corticosteroid pharmaceutical product. This non-set-aside, firm fixed-price delivery order was awarded on September 12, 2025, with an ultimate completion date of September 15, 2025. The product will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a $1,144.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for Solu-Cortef 100 mg Act-O-Vials on August 12, 2025, with an ultimate completion date of August 13, 2025. This delivery order is unclassified as a set-aside contract and represents a child award under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Medical Supply Chain awarded a $15,484.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 6, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order calls for pharmaceutical products...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,535.20 to AmerisourceBergen Drug Corp on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,197.66 to AmerisourceBergen Drug Corp on August 9, 2025, with completion scheduled for August 11, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract valued at $45,231.48 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $1,444.50 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award employs firm fixed pricing with no set-aside designation,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,229.04 to AmerisourceBergen Drug Corp on September 7, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from the vendor's Corporate Office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYBMDelivery Order
The Defense Logistics Agency awarded a $5,162.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cortrosyn 0.25 mg vials, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was issued on September 19, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery order is consistent with AmerisourceBergen's extensive role as a critical federal medical procurement vendor supplying pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's federal contract portfolio demonstrates its capability to fulfill diverse medical supply needs through competitive procurement, with delivery orders ranging from minimal to substantial values under firm fixed pricing structures. The Cortrosyn order exemplifies the company's continued support of the Defense Health Agency and broader military healthcare programs through the comprehensive global pharmaceutical support vehicle established by DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 9/19/25 |